Guixiong Fan

1.2k total citations · 1 hit paper
33 papers, 824 citations indexed

About

Guixiong Fan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Guixiong Fan has authored 33 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Guixiong Fan's work include Neuroendocrine Tumor Research Advances (9 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Guixiong Fan is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Guixiong Fan collaborates with scholars based in China, United States and Australia. Guixiong Fan's co-authors include Yi Qin, Shunrong Ji, Xiaowu Xu, Xianjun Yu, Qifeng Zhuo, Wenyan Xu, Wensheng Liu, Qiangsheng Hu, Ye Zeng and Mengqi Liu and has published in prestigious journals such as Cancer Research, Oncogene and Advanced Science.

In The Last Decade

Guixiong Fan

30 papers receiving 822 citations

Hit Papers

Lactate‐induced protein lactylation: A bridge between epi... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guixiong Fan China 14 553 381 322 221 87 33 824
Qifeng Zhuo China 13 584 1.1× 451 1.2× 326 1.0× 300 1.4× 92 1.1× 36 933
Yen‐Nien Liu Taiwan 20 700 1.3× 483 1.3× 401 1.2× 284 1.3× 39 0.4× 37 1.1k
Zhenqing Ye United States 12 455 0.8× 257 0.7× 247 0.8× 227 1.0× 48 0.6× 18 861
Ju Mei China 19 520 0.9× 314 0.8× 160 0.5× 117 0.5× 85 1.0× 37 750
Xinpei Ci Canada 15 446 0.8× 261 0.7× 261 0.8× 130 0.6× 38 0.4× 23 691
Maria Quiles del Rey United States 7 373 0.7× 341 0.9× 151 0.5× 108 0.5× 73 0.8× 8 625
Zhefang Wang Germany 11 535 1.0× 422 1.1× 191 0.6× 335 1.5× 46 0.5× 19 908
Wenyi Zhao China 18 445 0.8× 337 0.9× 231 0.7× 236 1.1× 70 0.8× 43 879
Hongjing Zang China 17 536 1.0× 242 0.6× 188 0.6× 223 1.0× 53 0.6× 42 769

Countries citing papers authored by Guixiong Fan

Since Specialization
Citations

This map shows the geographic impact of Guixiong Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixiong Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixiong Fan more than expected).

Fields of papers citing papers by Guixiong Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guixiong Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixiong Fan. The network helps show where Guixiong Fan may publish in the future.

Co-authorship network of co-authors of Guixiong Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Guixiong Fan. A scholar is included among the top collaborators of Guixiong Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guixiong Fan. Guixiong Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Borui, Ting Wang, Haifeng Hu, et al.. (2025). Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacologica Sinica. 46(6). 1742–1756. 4 indexed citations
3.
Dang, Qin, Ting Wang, Yan Wang, et al.. (2025). ACSS2/AATF Drives Soluble FasL‐Mediated CD8 + T Cell Apoptosis in Pancreatic Neuroendocrine Tumors. Advanced Science. 12(40). e06883–e06883.
4.
Lou, Xin, Yi Qin, Wuhu Zhang, et al.. (2025). Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors. Cell Death and Disease. 17(1). 35–35.
5.
Jia, Yuming, Ye Zeng, Xin Wang, et al.. (2024). <italic>NCOA6</italic> knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine. Acta Biochimica et Biophysica Sinica. 57(8). 1260–1269. 2 indexed citations
6.
Fan, Guixiong, Qin Dang, Shunrong Ji, et al.. (2024). Transcription factor EB reprograms branched‐chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1. Cell Proliferation. 57(11). e13694–e13694. 7 indexed citations
7.
Zeng, Ye, Qiang Li, Wuhu Zhang, et al.. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters. 588. 216769–216769. 9 indexed citations
8.
Wang, Jingyi, Xiaohong Wang, Chenjie Zhou, et al.. (2024). YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. Cancer Letters. 602. 217197–217197. 3 indexed citations
9.
Zeng, Ye, Zheng Li, Guixiong Fan, et al.. (2023). Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Proliferation. 56(10). e13478–e13478. 107 indexed citations breakdown →
10.
Zhuo, Qifeng, Heli Gao, Yi Qin, et al.. (2023). MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression. Cancer Research. 83(13). 2226–2247. 20 indexed citations
11.
Wang, Ting, Yi Qin, Ye Zeng, et al.. (2023). A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacologica Sinica. 44(8). 1536–1548. 12 indexed citations
12.
Xu, Junfeng, Zheng Li, Qifeng Zhuo, et al.. (2022). Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway. Frontiers in Oncology. 12. 822039–822039. 7 indexed citations
13.
Hu, Qiangsheng, Yi Qin, Shunrong Ji, et al.. (2021). MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Research. 81(19). 4964–4980. 31 indexed citations
14.
Zhang, Zheng, Yi Qin, Shunrong Ji, et al.. (2021). FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. Acta Biochimica et Biophysica Sinica. 53(8). 997–1008. 14 indexed citations
15.
Liu, Mengqi, Qiangsheng Hu, Yi Qin, et al.. (2021). SETD8 induces stemness and epithelial–mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression. Acta Biochimica et Biophysica Sinica. 53(12). 1614–1624. 8 indexed citations
16.
Liu, Mengqi, Yi Qin, Qiangsheng Hu, et al.. (2020). SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. Cancer Letters. 499. 265–278. 22 indexed citations
17.
Zhang, Zheng, Mengqi Liu, Shunrong Ji, et al.. (2020). Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors. Pancreas. 49(3). 381–386. 14 indexed citations
18.
Zeng, Ye, Qifeng Zhuo, Qiangsheng Hu, et al.. (2020). FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biology. 38. 101807–101807. 202 indexed citations
19.
Zeng, Ye, Wensheng Liu, Qifeng Zhuo, et al.. (2020). Ferroptosis: Final destination for cancer?. Cell Proliferation. 53(3). e12761–e12761. 93 indexed citations
20.
Zhang, Zheng, Mengqi Liu, Qiangsheng Hu, et al.. (2019). FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer.. PubMed. 9(12). 2650–2664. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026